ATR and breast cancer: The patient carrying this variant was a BC case who also presented other benign variants in MLH1 and BRCA1, a VUS in UIMC1, as well as the novel variant p.Pro932Thr in ATR. As previously described, truncating variants on MMR proteins are known for increasing the risk for both BC and OC [70–72].